The boundary between biology and technology is fading. Biotech startups and labs are developing wearable health trackers, gene-editing tools, AI-powered diagnostics, and even brain-computer interfaces. These tools promise better health outcomes, faster drug discovery, and a future where disease is detected before symptoms appear.
This post examines how platforms like CRISPR, neural interfaces, and biosensor patches are revolutionizing health and longevity. It discusses the potential to eliminate genetic disease and the ethical dilemmas around enhancement vs. treatment. As software starts reading and rewriting biology, biotech is poised to redefine what it means to be human.
